Summary
Hepatic drug metabolism in patients with acute viral hepatitis was investigated under different conditions: pregnancy, postpartum, non-pregnancy, and among males. Liver function tests were altered in all of these conditions. The relationship betweenin vivo andin vitro drug metabolism was studied in twenty-two patients using diagnostic liver needle biopsies by comparing the drug metabolising enzymes (aminopyrine-N-demethylase and bilirubin-UDP-glucuronyl transferase) in these biopsies with the elimination kinetics of antipyrine. Drug clearance tests were repeated in the patients who had recovered. All patients gave altered liver function tests results. Antipyrine half-life was significantly higher in females as compared to males. Among females, it was maximum in the pregnant group. Activities of drug metabolising enzymes were found to be significantly lower in liver biopsy material. The half-life of antipyrine showed a significant correlation with drug metabolising enzymes. After recovery patients showed a normal antipyrine half-life.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Levy A.J., Sherlock S. and Walker D. (1968): Phenylbutazone and isoniazid metabolism in patients with liver disease, in relation to previous drug therapy. Lancet,1, 1275–1279.
Mawer G.E., Miller N.E. and Turnberg L. (1972): Metabolism of amylobarbitone in patients with chronic liver disease. Brit. J. Pharmacol.44, 549–560.
Branch R.A., Herbert C.M. and Read A.E. (1973): Determination of serum antipyrine half-lives in patients with liver disease. Gut,14, 569–573.
Burnett D.A., Barak A.J., Tuna D.J. and Soirell M.F. (1976): Altered elimination of antipyrine in patients with acute viral hepatitis. Gut,17, 341–344.
Forrest J.A.H., Finlayson N.D.C., Adjepon-Yomoah K.K. and Prescott L.F. (1977): Antipyrine, Paracetamol and lignocaine elimination in chronic liver disease. Brit. Med. J.,1, 1384–1387.
Noordhoek J., Dees J., Sevenije-Chapel E.M., Wilson J.H.P. (1978): Output of 14 C02 in breath after oral administration of (14 C-methyl) aminopyrine in hepatitis, cirrhosis and hepatic bilharziasis: Its relationship to aminopyrine pharmacokinetics. Eur. J. Clin. Pharmacol.,13, 223–229.
Homeida M, Roberts C.J.C, Halliwell M, Read A.E. and Branch R.A. (1979): Antipyrine clearance perunit volume liver: an assessment of Hepatic function in chronic liver disease. Gut,20, 596–602.
Datta D.V. (1977): Viral hepatitis. J. Assoc. Phys. India25, 325–330.
Schull H.J., Wilkinson G.R., Johnson R, and Schenker S. (1976): Normal disposition of oxazepam in acute viral hepatits. Ann. Int. Med.84, 420–425.
Brodie B.B., Axelord J., Soberman R. and Levy BB. (1949): The estimation of antipyrine in biological materials. J. Biol. Chem,179, 25–29.
Notari A.E., De Young J.L. and Anderson R.C (1975): Biopharmacontics and Pharmacokinetics. An introduction. New York, Marcel Dekker, Inc.
Schoene B, Fleischmann R.A., Remmer H and v Olderhausan H.F. (1972): Determination of drug metabolizing enzymes in needle biopsies of human liver. Eur. J. Clin. Pharmacol.,4, 65–73.
Black M. Billing, B.H. and Heiruegh K.P.M. (1970): Determination of bilirubin UDP-glucuronyl transferase activity in needle biopsy specimens of human liver. Clin. Chim. Acta,29, 27–35.
Lowry O.H., Rosebrough N.J., Ferr A.L. and Randall R.J. (1951): Protein measurement with Folin-phenol reagent. J. Biol. Chem.,193, 265–273.
Freund J.E. Liverpore P.E. and Miller I (1960): Manual of experimental statistics. Engleweed Cliffs, Prentice Hall. Inc.
Neale M.G. and Perke D.V. (1973): Effect of pregnancy on the metabolism of drug in the rat and rabbit. Biochem. Pharmacol.22, 1451–1461.
Brodie B.B. and Axelrod J. (1950): The fate of antipyrine in man. J. Pharmacol. Exp. Ther.,98, 97–104.
Stevenson LH. (1977): Factors influencing antipyrine elimination. Brit. J. Clin. Pharmacol,4, 261–265.
Huffman D.H., Showman D.W. and Azarnoff D.L. (1974): Correlation of the plasma elimination of antipyrine and the appearance of 4-hydroxyantipyrine in the urine of man. Biochem. Pharmacol.,23, 197–201.
Preisig R, Rankin J.G., Sweeting J. and Bradley S.E. (1966): Hepatic hemodynamics druingviral hepatitis in man. Circulation34, 188–197.
Shand D.G. (1977): Drug disposition in liver disease. New Engl. J. Med.,296, 1527–1528.
Willson R.A., Hart F.E. and Hew J.T. (1979): Comparison of in vivo and in vitro drug metabolism in experimental hepatic injury in the rat. Gastroenterology,76, 697–703.
Sotaniemi E.A., Ahlovist J., Pelkoman R.O., Pirttiaho H. and Luoma P.V., (1977): Histological changes in the liver and indices of drug metabolism in alcoholics. Eur. J. Clin. Pharmacol.,11, 295–303.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Narang, A.P.S., Datta, D.V., Nath, N. et al. Impairment of hepatic drug metabolism in patients with acute viral hepatitis. European Journal of Drug Metabolism and Pharmacokinetics 7, 255–258 (1982). https://doi.org/10.1007/BF03189627
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF03189627